Amgen, AstraZeneca''s Tezspire for severe asthma gets approval in Japan
Amgen (AMGN) and AstraZeneca''s (AZN) Tezspire was approved in Japan for a broad population of patients with severe asthma with no phenotype or biomarker limitations. Tezspire…
Amgen, AstraZeneca''s Tezspire for severe asthma gets approval in Japan
Amgen (AMGN) and AstraZeneca''s (AZN) Tezspire was approved in Japan for a broad population of patients with severe asthma with no phenotype or biomarker limitations. Tezspire…